Pre-procedural Anxiety and Sedation.
Does Pre-procedural Anxiety Affect the Consumption of Sedatives During Colonoscopy?
1 other identifier
observational
75
1 country
1
Brief Summary
Colonoscopy is an outpatient procedure performed frequently as a screening test for diagnosis and treatment of a wide range of gastrointestinal problems. It is often viewed as an invasive procedure with the potential for embarrassment, discomfort, and worry. Such fears can result in anxiety that may decrease the tolerance and cooperation of the patient, limit the success of the procedure, and increase the likelihood of complications. Therefore, colonoscopy is frequently performed under sedation. The anxiety level of the patient before the procedure may increase the requirement for sedation. It is important for the anesthesiologist to predict the effective dosages of sedation before the procedure to ensure rapid and comfortable sedation as well as prompt recovery and discharge of the patient. This prospective cohort study is planned to evaluate the effects of pre-procedural anxiety level on the dose of propofol needed for patient and surgeon satisfaction during colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 25, 2013
CompletedFirst Posted
Study publicly available on registry
October 9, 2013
CompletedOctober 9, 2013
October 1, 2013
8 months
September 25, 2013
October 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the effects of pre-procedural anxiety level on the dose of propofol needed for sedation during the procedure.
The sedation protocol applied in this study is our routin approach for all outpatient colonoscopies and endoscopies. All patients are informed about the procedures and monitorized (EKG, spO2, Bispectral index, blood pressure). After that, the sedation protocol is started and once the appropriate BIS value is reached the procedure is started. For this study all patients were asked to complete the STAI scores to evaluate the pre-procedural anxiety. This is not an intervention but an evaluation of the patients' anxiety. The primary outcome measure is to evaluate the dose of propofol used in each patient and to find out if there is a correlation between the pre-procedural anxiety and the dose of propofol.
The anxiety of all patients is evaluated at the day of the procedure. The procedure is then performed under sedation. Once the procedure is ended and all patients are fully awake, study data are collected and patients are discharged home.
Study Arms (1)
Sedated colonoscopy
Planned colonoscopies for screening under propofol sedation titrated to reach a bispectal index value of 60. Anxiety levels are assessed before the procedure with State-Trait Anxiety Inventory Scores.
Interventions
Patients are evaluated before the procedure with State-Trait Anxiety Inventory scores to determine the anxiety level.
Eligibility Criteria
75 healthy patients undergoing elective colonoscopies as a screening test.
You may qualify if:
- American Society of Anaesthesiology Physiologic assessment score I-II patients
- years old
- planned elective colonoscopy under sedation
You may not qualify if:
- the use of anxiolytic medications
- history of colonic resection or any intraabdominal surgery
- predicted allergy to propofol
- patients refusing sedation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Basak Ceyda MECOlead
Study Sites (1)
Ankara University Faculty of Medicine, Ibni Sina Hospital colonoscopy lab
Ankara, 06700, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Basak Ceyda MECO, MD, DESA
Ankara University Faculty of Medicine
- STUDY DIRECTOR
Mehmet Ayhan Kuzu, Prof
Ankara University Faculty of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD,DESA
Study Record Dates
First Submitted
September 25, 2013
First Posted
October 9, 2013
Study Start
January 1, 2013
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
October 9, 2013
Record last verified: 2013-10